Article
Global Status of Ethambutol Resistance in Mycobacterium tuberculosis Clinical Isolates: An Updated Systematic Review and Meta-Analysis.
Microbial drug resistance (Larchmont, N.Y.) - 1 Aug 2026
Dai Xiting, Wu Hanxin, Zhu Liangyu, Chen Zhiqiang, Ma Weijie, Peng Li, Yang Rui, Luo Suyi, Bao Fukai, Liu Aihua
Abstract excerpt
Ethambutol (EMB) serves as a critical first-line antimycobacterial agent pivotal in the management of Mycobacterium tuberculosis. The emergence of resistance to EMB, primarily driven by mutations in the embB gene, constitutes a formidable challenge to global tuberculosis (TB) eradication efforts. This meta-analysis followed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
